BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10638956)

  • 1. Position paper by the UKCCCR elderly cancer patients in clinical trials working group.
    Br J Cancer; 2000 Jan; 82(1):1-3. PubMed ID: 10638956
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
    Townsley CA; Chan KK; Pond GR; Marquez C; Siu LL; Straus SE
    BMC Cancer; 2006 Feb; 6():34. PubMed ID: 16466574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
    Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA
    J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.
    Talarico L; Chen G; Pazdur R
    J Clin Oncol; 2004 Nov; 22(22):4626-31. PubMed ID: 15542812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing entry of the elderly into cancer clinical trials: difficult, but unquestionably necessary.
    Markman M
    Oncology; 2007; 72(1-2):2-3. PubMed ID: 17971678
    [No Abstract]   [Full Text] [Related]  

  • 6. The cancer and leukemia group B cancer in the elderly committee: addressing a major cancer need.
    Cohen HJ; Muss HB
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3606s-11s. PubMed ID: 16740793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elderly lung cancer patients: what treatment strategies?
    Gridelli C
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1331-4. PubMed ID: 17944557
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients 65 years of age or older in cancer-treatment trials.
    Bartlett EE
    N Engl J Med; 2000 May; 342(20):1531. PubMed ID: 10819657
    [No Abstract]   [Full Text] [Related]  

  • 9. Health related quality of life outcomes in cancer clinical trials.
    Bottomley A; Flechtner H; Efficace F; Vanvoorden V; Coens C; Therasse P; Velikova G; Blazeby J; Greimel E;
    Eur J Cancer; 2005 Aug; 41(12):1697-709. PubMed ID: 16043345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials.
    Markman M; Petersen J; Montgomery R
    Cancer; 2006 Aug; 107(4):849-53. PubMed ID: 16832813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer treatment and the older patient.
    Trimble EL; Christian MC
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1956-7. PubMed ID: 16609002
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliable evidence of safety and efficacy of elderly patients in randomized clinical trials still needed.
    Crean SM; Reynolds MW; Dematto CA
    J Clin Oncol; 2007 Sep; 25(25):4027-8; author reply 4028. PubMed ID: 17761994
    [No Abstract]   [Full Text] [Related]  

  • 14. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?
    Efficace F; Novik A; Vignetti M; Mandelli F; Cleeland CS
    Haematologica; 2007 Dec; 92(12):1596-8. PubMed ID: 18055981
    [No Abstract]   [Full Text] [Related]  

  • 15. Never too old? Age should not be a barrier to enrollment in cancer clinical trials.
    Aapro MS; Köhne CH; Cohen HJ; Extermann M
    Oncologist; 2005 Mar; 10(3):198-204. PubMed ID: 15793223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying motivations and barriers to patient participation in clinical trials.
    Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P
    J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?
    Yee KW; Pater JL; Pho L; Zee B; Siu LL
    J Clin Oncol; 2003 Apr; 21(8):1618-23. PubMed ID: 12697888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of clinical trials for adolescents and young adults with cancer.
    Ferrari A; Montello M; Budd T; Bleyer A
    Pediatr Blood Cancer; 2008 May; 50(5 Suppl):1101-4. PubMed ID: 18360838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geriatric oncology aims for clinical trials.
    Sinha G
    J Natl Cancer Inst; 2006 Nov; 98(21):1516-8. PubMed ID: 17077352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.